NIFEDEMINT Trademark

Trademark Overview

On Tuesday, April 5, 2016, a trademark application was filed for NIFEDEMINT with the United States Patent and Trademark Office. The USPTO has given the NIFEDEMINT trademark a serial number of 86964638. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 22, 2019. This trademark is owned by STAT CAPSULE INC.. The NIFEDEMINT trademark is filed in the Pharmaceutical Products category with the following description:

liquid medication, namely, nifedepine-based medication in capsular form for treating high blood pressure and angina
nifedemint

General Information

Serial Number86964638
Word MarkNIFEDEMINT
Filing DateTuesday, April 5, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 22, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2017

Trademark Statements

Goods and Servicesliquid medication, namely, nifedepine-based medication in capsular form for treating high blood pressure and angina

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 8, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSTAT CAPSULE INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGlendale, CA 91205
Party NameSTAT CAPSULE INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGlendale, CA 91205

Trademark Events

Event DateEvent Description
Monday, April 22, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 22, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 15, 2018EXTENSION 3 GRANTED
Saturday, September 15, 2018EXTENSION 3 FILED
Saturday, September 15, 2018TEAS EXTENSION RECEIVED
Wednesday, March 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 19, 2018EXTENSION 2 GRANTED
Monday, March 19, 2018EXTENSION 2 FILED
Monday, March 19, 2018TEAS EXTENSION RECEIVED
Wednesday, August 30, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 28, 2017EXTENSION 1 GRANTED
Monday, August 28, 2017EXTENSION 1 FILED
Monday, August 28, 2017TEAS EXTENSION RECEIVED
Tuesday, March 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2017PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 12, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 9, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 8, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 8, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 25, 2016NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, July 25, 2016PRIORITY ACTION E-MAILED
Monday, July 25, 2016PRIORITY ACTION WRITTEN
Wednesday, July 20, 2016ASSIGNED TO EXAMINER
Friday, April 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

nifedemint medication high blood angina treating pressure capsular namely nifedepine based